Loading...
Loading...
In a research report published earlier today by Wunderlich Securities, Cavium
CAVM announced that its Q1 revenue will be down 6-7%, compared to guidance for revenues to be flattish.
According to the report, “NonGAAP EPS is now expected to be $0.00, compared to original guidance of $0.06-$0.07. We believe our thesis for our Sell rating, which includes slowing growth, competitive headwinds, and unsustainable and difficult-to-justify valuation of 5.6x EV/2013E sales, remains intact. We maintain our Sell rating and are lowering our 2012 and 2013 estimates and price target to $18 from $20.”
Cavium closed yesterday at $30.57.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in